TSOLUDOSE 75 microgrammes, solution buvable en récipient unidose — 30 récipients unidoses en polyéthylène basse densité (PEBD) de 1 mL conditionnés en sachets de 5 récipients unidoses
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930165096 -
CIP7
3016509 -
CIS
68190442
What the source publishes
- Holder
- IBSA PHARMA SAS
- Active ingredients
- LÉVOTHYROXINE SODIQUE, LÉVOTHYROXINE SODIQUE ANHYDRE
- Form
- solution buvable
- Package
- 30 récipients unidoses en polyéthylène basse densité (PEBD) de 1 mL conditionnés en sachets de 5 récipients unidoses
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- liste II
- Marketing status
- Déclaration d'arrêt de commercialisation
- Authorised on
- 2018-11-23
- Prescription
- Prescription or restricted
Names this record is found by
- TSOLUDOSE 75 microgrammes, solution buvable en récipient unidose — 30 récipients unidoses en polyéthylène basse densité (PEBD) de 1 mL conditionnés en sachets de 5 récipients unidoses
- TSOLUDOSE 75 microgrammes, solution buvable en récipient unidose
- LÉVOTHYROXINE SODIQUE
- LÉVOTHYROXINE SODIQUE ANHYDRE
Complete source data
{
"cis": "68190442",
"cip7": "3016509",
"form": "solution buvable",
"name": "TSOLUDOSE 75 microgrammes, solution buvable en récipient unidose — 30 récipients unidoses en polyéthylène basse densité (PEBD) de 1 mL conditionnés en sachets de 5 récipients unidoses",
"cip13": "3400930165096",
"holder": "IBSA PHARMA SAS",
"routes": [
"orale"
],
"holders": [
"IBSA PHARMA SAS"
],
"currency": "EUR",
"marketed": false,
"bdmStatus": "Warning disponibilité",
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2018-11-23",
"compositions": [
{
"name": "LÉVOTHYROXINE SODIQUE",
"nature": "SA",
"strength": null,
"linkageNumber": "1",
"substanceCode": "00382",
"dosageReference": null,
"pharmaceuticalElement": "solution"
},
{
"name": "LÉVOTHYROXINE SODIQUE ANHYDRE",
"nature": "FT",
"strength": "75 microgrammes",
"linkageNumber": "1",
"substanceCode": "52118",
"dosageReference": "1 mL de solution",
"pharmaceuticalElement": "solution"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "liste II",
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "TSOLUDOSE 75 microgrammes, solution buvable en récipient unidose",
"marketingStatus": "Déclaration d'arrêt de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "non",
"packageDescription": "30 récipients unidoses en polyéthylène basse densité (PEBD) de 1 mL conditionnés en sachets de 5 récipients unidoses",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2024-11-13",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"LÉVOTHYROXINE SODIQUE",
"LÉVOTHYROXINE SODIQUE ANHYDRE"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [
"liste II"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930165096"